| 000 | 01400 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514062240.0 | ||
| 264 | 0 | _c20031007 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0392-9078 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAksaz, E | |
| 245 | 0 | 0 |
_aTNF-alpha levels in patients with malignant tumors after hyperthermic isolated regional perfusion. _h[electronic resource] |
| 260 |
_bJournal of experimental & clinical cancer research : CR _cDec 2002 |
||
| 300 |
_a489-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aChemotherapy, Cancer, Regional Perfusion _xmethods |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthermia, Induced _xmethods |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 |
_aReperfusion Injury _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aErdem, E | |
| 700 | 1 | _aErdem, D | |
| 700 | 1 | _aUnal, A M | |
| 773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 21 _gno. 4 _gp. 489-93 |
|
| 999 |
_c12430692 _d12430692 |
||